YouTube TV and Fox Corp are in a standoff ahead of a deadline for a distribution deal Wednesday evening. Google's YouTube said it may remove channels like Fox Broadcast Network, Fox News and Fox Sports from its streaming service if the two sides can't reach an agreement.

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fiserv, Inc. (NYSE: FI) between July 24, 2024 and July 22, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline.

WARREN, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today updated investors of its significant internally developed assets, which under U.S. GAAP accounting rules are not reflected on the Company's balance sheet, yet represent substantial long-term value. Tevogen will provide detailed information and valuation of these assets in the coming days.

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025 (the “Class Period”), of the important October 6, 2025 lead plaintiff deadline.

Micron Technology, Inc. is a key player in AI infrastructure, with memory demand poised to break historic business cycles and drive long-term growth. AI-driven demand is boosting DRAM/NAND markets, supporting higher margins and revenue growth, especially in data center/server segments through 2027. Despite strong fundamentals, Micron trades at low valuations, 6.1x P/CE or a 0.4x PEG, offering significant upside if the market recognizes its pivotal AI role.

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: ANRO): (i) pursuant and/or traceable to Alto's initial public offering conducted on or about February 2, 2024 (the “IPO”); and/or (ii) securities between February 2, 2024 and October 22, 2024, both dates inclusive (the “Class Period”), of the important September 19, 2025 lead plaintiff deadline.

Stacy Rasgon, Bernstein semiconductor analyst, joins 'Power Lunch' to discuss Nvidia's quarterly earnings results, how much institutional interest still exists with Nvidia and much more.

Nuvaxovid™ is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season GAITHERSBURG, Md. , Aug. 27, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration has approved the Nuvaxovid™ 2025-2026 Formula for the prevention of COVID-19 in adults 65 years and older or individuals 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19.

NEW YORK--(BUSINESS WIRE)---- $LFMD #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) and reminds investors of the October 27, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has r.

Circle and Paxos Trust reportedly devised a way to help companies verify digital asset holdings. The two firms are working with Bluprynt, a FinTech startup founded by Georgetown Law School professor Chris Brummer, Bloomberg reported Wednesday (Aug. 27).

As noted by R. "Ray" Wang, Nvidia (NVDA) beat and raised for eight consecutive quarters, and he believes the company can do it again.

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of PubMatic, Inc. (NASDAQ: PUBM) between February 27, 2025 and August 11, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 20, 2025.

Mastercard solidifies its Circle partnership to bring USDC and EURC settlements to acquirers across the EEMEA region as well as promote widespread adoption of stablecoins in the region.

Williams-Sonoma's NYSE: WSM stock price action and results history do not precisely match up; investors should focus on the results history. It includes persistent outperformance in the face of consumer headwinds, brand resilience, pricing power, margin strength, robust cash flow, and capital returns.

Amazon.com, Inc.'s ability to monetize the ongoing AI boom has been undisputed, as observed in the richer LTM operating margins and the growing multi-year backlog. If anything, its new growth driver, advertising, is likely to drive further margin expansion, thanks to the growth flywheel from commerce, Prime subscription/ streaming, and logistics capabilities. These have led to the giant's outsized FQ2 '25 top/ bottom-line growth profile compared to the prior guidance, with a further outperformance likely in FQ3 '25.

NEW YORK , Aug. 27, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025 and July 28, 2025, both dates inclusive (the "Class Period"), of the important September 30, 2025 lead plaintiff deadline. So What: If you purchased Novo Nordisk securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

I built a preferred stock portfolio starting in 2022 in anticipation of falling inflation and interest rates, which has delivered strong double-digit returns. With fiscal and monetary policy now more aligned, I expect inflation to return to the Fed's 2% target and falling interest rates creating further upside for preferred stocks and ETFs. Preferred stocks RITM.PR.D, ABR.PR.F, CIM.PR.C, and ETFs PFFA, PFFR, and PFXF should benefit from declining rates over the next year.

Investors need to pay close attention to T. Rowe Price Group stock based on the movements in the options market lately.

AppLovin's AI-fueled Axon 2 and soaring profitability give APP a stronger near-term edge over ARM's steadier chip-driven growth.

Daqo New Energy's Q2 results were weak due to industry oversupply and low polysilicon prices, but the company's strong balance sheet stands out. Despite negative margins and losses, DQ's cash reserves and lack of debt position it to outlast weaker competitors in this downturn. Industry consolidation and capacity cuts are expected to stabilize prices, enabling DQ to gain market share and benefit from the next upcycle.